Sput­nik V tech un­suit­able for com­mer­cial man­u­fac­tur­ing

Business Standard - - POLITICS -

Hy­der­abad’s Dr Reddy’s Lab­o­ra­to­ries has inked a dis­tri­bu­tion deal with Rus­sian Di­rect In­vest­ment Fund (RDIF) for Sput­nik V, but In­dian play­ers in talks with RDIF say the tech­nol­ogy is not suited for com­mer­cial man­u­fac­tur­ing.

It is also learnt that play­ers like In­dian Im­muno­log­i­cals (IIL) have opted out of the talks for man­u­fac­tur­ing in In­dia. The same could not be im­me­di­ately ver­i­fied with the com­pany. Ac­cord­ing to sources, firms like Serum In­sti­tute, Bi­o­log­i­cal E, Zy­dus Cadila, and IIL were in talks with RDIF.

Ac­cord­ing to Tass, in the past one month, over 3,000 Mus­covites have re­ceived the Sput­nik V jab.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.